Cardiac Imaging

What Imaging Should You Order for a High-Risk Asymptomatic Patient for Coronary Artery Disease?

·
What Imaging Should You Order for a High-Risk Asymptomatic Patient for Coronary Artery Disease?

It’s 4:30 PM on a Tuesday, and you’re seeing your last patient, a 62-year-old man with a family history of premature coronary artery disease (CAD), longstanding hypertension, and hyperlipidemia. He feels perfectly fine, with no chest pain, shortness of breath, or exertional symptoms. His calculated 10-year atherosclerotic cardiovascular disease (ASCVD) risk score is 22%, placing him firmly in the high-risk category. You’ve initiated statin therapy, but both you and the patient are wondering: what is his actual plaque burden? This article details the American College of Radiology (ACR) workflow for selecting initial imaging in this specific scenario. For an asymptomatic, high-risk patient, the ACR rates CT coronary calcium as May be appropriate.

Who Fits This Clinical Scenario?

This guidance applies to a specific patient population: asymptomatic adults who are considered at high risk for coronary artery disease and are undergoing initial evaluation. “High risk” is typically defined by a 10-year ASCVD risk score of 20% or higher, though it can also include patients with a strong family history of premature CAD or other compelling risk factors as determined by the clinician.

Crucially, the patient must be completely asymptomatic. The presence of any symptoms suggestive of cardiac ischemia, such as chest pain, dyspnea on exertion, or anginal equivalents, immediately moves the patient into a different diagnostic pathway focused on detecting flow-limiting stenosis, not simply risk-stratifying subclinical disease.

This workflow should be distinguished from two similar, but distinct, clinical situations:

  • Low-Risk Asymptomatic Patients: Individuals with an ASCVD score <5%. Imaging is generally not indicated in this group as the pre-test probability of significant findings is low and may lead to unnecessary downstream testing.
  • Intermediate-Risk Asymptomatic Patients: Those with an ASCVD score of 5% to <20%. Imaging can be a powerful tie-breaker in this group to guide decisions on initiating or intensifying preventive therapies like statins.

This article focuses exclusively on the high-risk, asymptomatic individual where the clinical question is about confirming and quantifying the burden of atherosclerosis to guide the intensity of management.

What Diagnoses Are You Working Up in This Scenario?

In an asymptomatic patient, imaging is not used to diagnose an acute condition but to stratify future risk by identifying the presence and extent of subclinical disease. The primary goal is to refine the risk assessment provided by clinical risk scores.

Subclinical Coronary Atherosclerosis: This is the principal target of the workup. The presence of calcified plaque in the coronary arteries is direct evidence of atherosclerosis. The key question is not just if it’s present, but how much is present. A high burden of subclinical atherosclerosis significantly increases the patient’s risk of future myocardial infarction or cardiac death, often beyond what is predicted by risk scores alone. The imaging study aims to quantify this burden.

Concordance with Calculated Risk: A secondary goal is to determine if the patient’s anatomic disease burden aligns with their calculated high-risk status. Occasionally, a patient with a high calculated risk score may have a very low or zero coronary artery calcium score. This finding can be reassuring and may influence the intensity of pharmacotherapy, representing a patient whose actual risk may be lower than predicted by population-based models.

Absence of Significant Plaque Burden: Conversely, a key “ruling out” consideration is the absence of significant calcified plaque. A coronary artery calcium (CAC) score of zero is associated with a very low risk of cardiovascular events over the subsequent 5-10 years, providing powerful negative predictive value. This information can be invaluable for patient counseling and shared decision-making regarding long-term preventive strategies.

Why Is CT Coronary Calcium the Recommended Study for This Presentation?

For an asymptomatic, high-risk patient undergoing initial imaging, the ACR panel rates CT coronary calcium as May be appropriate. This non-contrast CT scan is designed specifically to detect and quantify calcium within the walls of the coronary arteries, which is a direct marker of atherosclerotic plaque.

The rationale for this choice is its proven ability to reclassify risk. The resulting Agatston score provides a quantitative measure of the total calcified plaque burden, which is a powerful independent predictor of future cardiac events. This information can move a patient from a generic “high-risk” category to a more personalized risk assessment, helping to guide the aggressiveness of lipid-lowering therapy, blood pressure control, and decisions about aspirin use.

Let’s compare this to other modalities considered by the ACR for this specific scenario:

  • CTA Coronary Arteries with IV Contrast: This study is also rated May be appropriate. While it provides more detailed anatomic information, including the visualization of non-calcified plaque and luminal stenosis, it involves both intravenous contrast and a higher radiation dose (☢☢☢ 1-10 mSv). For an initial, asymptomatic risk-stratification study, the added information and complexity are often not necessary. It is typically reserved for downstream evaluation of symptomatic patients or those with very high or equivocal CAC scores.
  • US Echocardiography Transthoracic Stress: This is rated Usually not appropriate. Stress testing is designed to detect myocardial ischemia caused by flow-limiting stenosis. In an asymptomatic patient, the primary clinical question is about the presence of plaque (risk stratification), not the functional consequence of that plaque (ischemia). Inducing ischemia in an asymptomatic patient is not the goal of initial screening.
  • SPECT or SPECT/CT MPI Rest and Stress: This nuclear medicine study is also rated Usually not appropriate for the same reason as stress echo. Furthermore, it involves a significantly higher radiation dose (☢☢☢☢ 10-30 mSv) compared to a CAC scan (☢☢☢ 1-10 mSv), making it unsuitable for a screening or initial risk-stratification role in this context.

The CT coronary calcium scan offers a rapid, low-dose, and non-invasive method to directly visualize the disease process in question—atherosclerosis—making it the most logical first imaging step. Once you’ve decided on this study, our protocol guide covers the technique and reading principles in detail: CT Coronary Calcium Score.

What’s Next After CT Coronary Calcium? Downstream Workflow

The result of the CT coronary calcium scan, the Agatston score, directly informs the next steps in management. The workflow is based on risk refinement and intensification of preventive therapy.

  • If the Agatston Score is 0 (No Calcified Plaque): This is a highly reassuring finding associated with a very low 10-year event rate. For a patient previously categorized as high-risk, this may prompt a discussion about de-escalating therapy or at least provide strong reinforcement against escalating it further. Re-scanning is typically not considered for at least 5 years.
  • If the Score is 1-99 (Mild Plaque Burden): This result confirms the presence of subclinical atherosclerosis and validates the decision to initiate statin therapy. It reinforces the importance of aggressive risk factor modification (blood pressure, diet, exercise).
  • If the Score is 100-399 (Moderate Plaque Burden): This finding indicates a significant plaque burden and a substantially increased risk. Management should be intensified, typically with a goal of achieving a lower LDL-C target with high-intensity statin therapy. A discussion about initiating aspirin for primary prevention may be appropriate, weighing the cardiovascular benefits against bleeding risks.
  • If the Score is >400 (Severe Plaque Burden): These patients are at very high risk for future events. This score mandates the most aggressive medical management, including high-intensity statins and rigorous control of all other risk factors. While the patient is still asymptomatic, some clinicians may consider a downstream functional study (like a stress test) to evaluate for inducible ischemia, though this remains a subject of clinical debate.

The CAC score serves as a powerful tool for shared decision-making, helping to motivate patients and guide the clinician’s therapeutic intensity.

Pitfalls to Avoid (and When to Get Help)

When ordering and interpreting imaging for this scenario, several common pitfalls can arise:

  • Ordering for the Wrong Reason: A CAC scan is a risk-stratification tool, not a diagnostic test for acute chest pain. Ordering it in a symptomatic patient delays the appropriate workup for ischemia.
  • Misinterpreting a Score of Zero: A score of zero means no calcified plaque is detected. It does not rule out the presence of non-calcified, “soft” plaque, which can also be vulnerable to rupture. However, the overall event rate remains extremely low in these patients.
  • Over-reacting to a High Score: A high CAC score in an asymptomatic patient is a marker of high risk, not an automatic indication for invasive coronary angiography. The appropriate response is aggressive medical therapy, not necessarily a referral to the catheterization lab.
  • Ignoring Clinical Context: The CAC score should always be interpreted in the context of the patient’s overall clinical picture, including age, sex, and traditional risk factors.

If a patient with a high CAC score develops any symptoms suggestive of angina, escalate immediately to a workup for ischemia, which may involve functional testing or coronary CTA.

Related ACR Topics and Tools

This article is a deep dive into one specific clinical scenario. For a broader view of imaging for asymptomatic patients at various risk levels, or to explore the tools used in this decision-making process, the following resources are essential.

Frequently Asked Questions

What ASCVD risk score defines a patient as ‘high risk’ for this scenario?

A 10-year atherosclerotic cardiovascular disease (ASCVD) risk score of 20% or greater is generally used to define a patient as high risk. However, clinical judgment may also place a patient in this category based on factors like a very strong family history of premature coronary disease.

Why not order a coronary CTA instead of a calcium score to see non-calcified plaque?

While a coronary CTA can visualize non-calcified plaque, it requires intravenous contrast and involves a higher radiation dose. For an initial, asymptomatic risk-stratification study, the robust prognostic data and simplicity of a non-contrast CT coronary calcium score make it the more appropriate first step. A CTA is typically reserved for subsequent evaluation if needed.

If my patient’s calcium score is zero, can I stop their statin?

A calcium score of zero is very reassuring and is associated with a low risk of cardiovascular events. This may justify a shared decision-making conversation about de-escalating or deferring statin therapy, especially if the patient is on the borderline of a treatment threshold. However, the decision should be individualized based on all risk factors, and current guidelines should be consulted.

Does a high calcium score in an asymptomatic patient mean they need a stent?

No. A high calcium score is a marker of extensive atherosclerosis and high future risk. It is an indication for aggressive medical management (e.g., high-intensity statins, strict blood pressure control) to stabilize plaque and prevent future events. It is not, by itself, an indication for coronary stenting, which is reserved for treating flow-limiting blockages that cause symptoms or acute coronary syndromes.

Why is a stress test ‘Usually not appropriate’ for this asymptomatic patient?

Stress tests are designed to detect myocardial ischemia, which is a lack of blood flow to the heart muscle typically caused by a severe blockage. In an asymptomatic patient, the clinical goal is to quantify the underlying plaque burden to stratify risk, not to provoke ischemia. The CT coronary calcium scan directly addresses the risk-stratification question.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026